S96 An open-label extension (ext) study of lumacaftor/ivacaftor (lum/iva) therapy in patients aged 6 to 11 years with cystic fibrosis (cf) homozygous for f508del-cftr
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.